Harvest Healthcare Valuation
| HHL Etf | CAD 8.14 0.02 0.25% |
At this time, the entity appears to be fairly valued. Harvest Healthcare retains a regular Real Value of C$8.2 per share. The prevalent price of the entity is C$8.14. Our model calculates the value of Harvest Healthcare from evaluating the entity fundamentals such as Total Asset of 276.16 M, last dividend paid of 0.0583, and Beta of 0.73 as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Harvest Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Harvest Healthcare is based on 3 months time horizon. Increasing Harvest Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Harvest Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Harvest Etf. However, Harvest Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.14 | Real 8.2 | Hype 8.15 |
The intrinsic value of Harvest Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Harvest Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Harvest Healthcare Leaders helps investors to forecast how Harvest etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Harvest Healthcare more accurately as focusing exclusively on Harvest Healthcare's fundamentals will not take into account other important factors: About Harvest Healthcare Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Harvest Healthcare Leaders. In general, an absolute valuation paradigm, as applied to this etf, attempts to find the value of Harvest Healthcare based exclusively on its fundamental and basic technical indicators. By analyzing Harvest Healthcare's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Harvest Healthcare's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Harvest Healthcare. We calculate exposure to Harvest Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Harvest Healthcare's related companies.The ETFs investment objective is to provide Unitholders with the opportunity for capital appreciation monthly cash distributions and lower overall volatility of portfolio returns than would otherwise be experienced by owning Equity Securities of the Healthcare Leaders directly. HARVEST HEALTHCARE is traded on Toronto Stock Exchange in Canada.
Other Information on Investing in Harvest Etf
Harvest Healthcare financial ratios help investors to determine whether Harvest Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Harvest with respect to the benefits of owning Harvest Healthcare security.